DEXA-KEL 02, injekcinis tirpalas
DEXA-KEL 02, injekcinis tirpalas
Not authorised
- Dexamethasone sodium phosphate
Product identification
Medicine name:
DEXA-KEL 02, injekcinis tirpalas
Active substance:
- Dexamethasone sodium phosphate
Target species:
-
Horse
-
Dog
-
Cattle
Route of administration:
-
Intraarticular use
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Dexamethasone sodium phosphate2.64/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intraarticular use
-
Horse
-
Meatno withdrawal periodNot authorized for use in horses, whose meat is meant for human consumption.
-
-
-
Intramuscular use
-
Horse
-
Meatno withdrawal periodNot authorized for use in horses, whose meat is meant for human consumption.
-
-
-
Intravenous use
-
Cattle
-
Meat16day
-
Milk72hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Surrendered
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/02/1450/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 27/02/2023